118 related articles for article (PubMed ID: 9767630)
1. Investigations of neurotrophic inhibitors of FK506 binding protein via Monte Carlo simulations.
Lamb ML; Jorgensen WL
J Med Chem; 1998 Oct; 41(21):3928-39. PubMed ID: 9767630
[TBL] [Abstract][Full Text] [Related]
2. Estimation of the binding affinities of FKBP12 inhibitors using a linear response method.
Lamb ML; Tirado-Rives J; Jorgensen WL
Bioorg Med Chem; 1999 May; 7(5):851-60. PubMed ID: 10400338
[TBL] [Abstract][Full Text] [Related]
3. Peptidyl-prolyl isomerase inhibitors.
Wang XJ; Etzkorn FA
Biopolymers; 2006; 84(2):125-46. PubMed ID: 16302169
[TBL] [Abstract][Full Text] [Related]
4. FKBP family proteins: immunophilins with versatile biological functions.
Kang CB; Hong Y; Dhe-Paganon S; Yoon HS
Neurosignals; 2008; 16(4):318-25. PubMed ID: 18635947
[TBL] [Abstract][Full Text] [Related]
5. Immunophilins: beyond immunosuppression.
Hamilton GS; Steiner JP
J Med Chem; 1998 Dec; 41(26):5119-43. PubMed ID: 9857082
[No Abstract] [Full Text] [Related]
6. Immunophilin ligands and GDNF enhance neurite branching or elongation from developing dopamine neurons in culture.
Costantini LC; Isacson O
Exp Neurol; 2000 Jul; 164(1):60-70. PubMed ID: 10877916
[TBL] [Abstract][Full Text] [Related]
7. Molecular anchors with large stability gaps ensure linear binding free energy relationships for hydrophobic substituents.
Rejto PA; Verkhivker GM
Pac Symp Biocomput; 1998; ():362-73. PubMed ID: 9697196
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of calcineurin inhibition by complexes of immunosuppressive drugs with human FK506 binding proteins.
Weiwad M; Edlich F; Kilka S; Erdmann F; Jarczowski F; Dorn M; Moutty MC; Fischer G
Biochemistry; 2006 Dec; 45(51):15776-84. PubMed ID: 17176100
[TBL] [Abstract][Full Text] [Related]
9. FK506-binding protein ligands: structure-based design, synthesis, and neurotrophic/neuroprotective properties of substituted 5,5-dimethyl-2-(4-thiazolidine)carboxylates.
Zhao L; Huang W; Liu H; Wang L; Zhong W; Xiao J; Hu Y; Li S
J Med Chem; 2006 Jul; 49(14):4059-71. PubMed ID: 16821768
[TBL] [Abstract][Full Text] [Related]
10. A Plasmodium falciparum FK506-binding protein (FKBP) with peptidyl-prolyl cis-trans isomerase and chaperone activities.
Monaghan P; Bell A
Mol Biochem Parasitol; 2005 Feb; 139(2):185-95. PubMed ID: 15664653
[TBL] [Abstract][Full Text] [Related]
11. The discovery of steroids and other novel FKBP inhibitors using a molecular docking program.
Burkhard P; Hommel U; Sanner M; Walkinshaw MD
J Mol Biol; 1999 Apr; 287(5):853-8. PubMed ID: 10222195
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of Mip, a prolylisomerase from Legionella pneumophila.
Riboldi-Tunnicliffe A; König B; Jessen S; Weiss MS; Rahfeld J; Hacker J; Fischer G; Hilgenfeld R
Nat Struct Biol; 2001 Sep; 8(9):779-83. PubMed ID: 11524681
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of PMF scoring in docking weak ligands to the FK506 binding protein.
Muegge I; Martin YC; Hajduk PJ; Fesik SW
J Med Chem; 1999 Jul; 42(14):2498-503. PubMed ID: 10411471
[TBL] [Abstract][Full Text] [Related]
14. Mean field analysis of FKBP12 complexes with FK506 and rapamycin: implications for a role of crystallographic water molecules in molecular recognition and specificity.
Rejto PA; Verkhivker GM
Proteins; 1997 Jul; 28(3):313-24. PubMed ID: 9223178
[TBL] [Abstract][Full Text] [Related]
15. Analyses of activity for factor Xa inhibitors based on Monte Carlo simulations.
Ostrovsky D; Udier-Blagović M; Jorgensen WL
J Med Chem; 2003 Dec; 46(26):5691-9. PubMed ID: 14667222
[TBL] [Abstract][Full Text] [Related]
16. X-ray structures of small ligand-FKBP complexes provide an estimate for hydrophobic interaction energies.
Burkhard P; Taylor P; Walkinshaw MD
J Mol Biol; 2000 Jan; 295(4):953-62. PubMed ID: 10656803
[TBL] [Abstract][Full Text] [Related]
17. Crystal structures of the free and ligand-bound FK1-FK2 domain segment of FKBP52 reveal a flexible inter-domain hinge.
Bracher A; Kozany C; Hähle A; Wild P; Zacharias M; Hausch F
J Mol Biol; 2013 Nov; 425(22):4134-44. PubMed ID: 23933011
[TBL] [Abstract][Full Text] [Related]
18. Establishment of a cell model based on FKBP12 dimerization for screening of FK506-like neurotrophic small molecular compounds.
Xiao H; Wang LL; Shu CL; Yu M; Li S; Shen BF; Li Y
J Biomol Screen; 2006 Apr; 11(3):225-35. PubMed ID: 16490780
[TBL] [Abstract][Full Text] [Related]
19. Think twice: understanding the high potency of bis(phenyl)methane inhibitors of thrombin.
Baum B; Muley L; Heine A; Smolinski M; Hangauer D; Klebe G
J Mol Biol; 2009 Aug; 391(3):552-64. PubMed ID: 19520086
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and cytotoxic evaluation of cycloheximide derivatives as potential inhibitors of FKBP12 with neuroregenerative properties.
Christner C; Wyrwa R; Marsch S; Küllertz G; Thiericke R; Grabley S; Schumann D; Fischer G
J Med Chem; 1999 Sep; 42(18):3615-22. PubMed ID: 10479292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
